www.bioworld.com/articles/493019
SPHINX'S PSORIASIS DRUG ENTERS PHASE II
Oct. 28, 1992
Sphinx Pharmaceuticals Corp. of Durham, N.C., said Tuesdaythat it has begun a Phase II clinical trial of its lead product,Kynac ointment, for treating the signs and symptoms ofpsoriasis.
(c) 1997 American Health Consultants. All rights reserved.